We are live on ! Find out more
BGIM

Brandywine Global Investment Management Portfolio holdings

AUM $14.9B
1-Year Est. Return 20.41%
This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
+20.41%
3 Year Est. Return
+61.22%
5 Year Est. Return
+111.48%
10 Year Est. Return
+294.16%
AUM
$12.4B
AUM Growth
-$417M
Cap. Flow
-$488M
Cap. Flow %
-3.94%
Top 10 Hldgs %
16.31%
Holding
789
New
69
Increased
242
Reduced
357
Closed
85

Top Buys

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$54.6M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.2M
3
AMGN icon
Amgen
AMGN
+$52.7M
4
LMT icon
Lockheed Martin
LMT
+$52.4M
5
NRG icon
NRG Energy
NRG
+$47.4M

Sector Composition

Rank Sector Weight
1 Financials 23.57%
2 Healthcare 17.02%
3 Industrials 10.83%
4 Energy 9.6%
5 Consumer Discretionary 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCCO icon
751
Southern Copper
SCCO
$165B
-995,581
Closed -$55.9M
SD icon
752
SandRidge Energy
SD
$529M
-50,931
Closed -$867K
SEE
753
DELISTED
Sealed Air
SEE
-129,191
Closed -$6.44M
SIGA icon
754
SIGA Technologies
SIGA
$206M
-116,137
Closed -$855K
SO icon
755
Southern Company
SO
$106B
-102,699
Closed -$7.33M
THG icon
756
Hanover Insurance
THG
$7.74B
-24,256
Closed -$3.28M
TWI icon
757
Titan International
TWI
$450M
-164,720
Closed -$2.52M
UNFI icon
758
United Natural Foods
UNFI
$2.9B
-218,177
Closed -$8.45M
UONEK icon
759
Urban One Class D
UONEK
$23.5M
-1,606
Closed -$60.4K
USB icon
760
US Bancorp
USB
$101B
-178,237
Closed -$7.77M
UWMC icon
761
UWM Holdings
UWMC
$2.42B
-56,510
Closed -$187K
VBTX
762
DELISTED
Veritex Holdings
VBTX
-86,105
Closed -$2.42M
VIR icon
763
Vir Biotechnology
VIR
$1.52B
-211,970
Closed -$5.36M
VIRT icon
764
Virtu Financial
VIRT
$5.04B
-194,579
Closed -$3.97M
VNDA icon
765
Vanda Pharmaceuticals
VNDA
$314M
-148,219
Closed -$1.1M
WOR icon
766
Worthington Enterprises
WOR
$2.78B
-211,845
Closed -$6.49M
WU icon
767
Western Union
WU
$2.23B
-210,652
Closed -$2.9M
XRX icon
768
Xerox
XRX
$412M
-629,447
Closed -$9.19M
ZBH icon
769
Zimmer Biomet
ZBH
$18.7B
-24,010
Closed -$3.06M
SASR
770
DELISTED
Sandy Spring Bancorp Inc
SASR
-84,091
Closed -$2.96M
HAYN
771
DELISTED
Haynes International, Inc.
HAYN
-86,877
Closed -$3.97M
SBOW
772
DELISTED
SilverBow Resources, Inc.
SBOW
-58,459
Closed -$1.65M
WRK
773
DELISTED
WestRock Company
WRK
-155,314
Closed -$5.46M
PACW
774
DELISTED
PacWest Bancorp
PACW
-138,326
Closed -$3.17M
FRBK
775
DELISTED
Republic First Bancorp Inc
FRBK
-779,331
Closed -$1.68M

Similar funds

Brandywine Global Investment Management's Q1 2023 Portfolio in Review

As of Q1 2023, Brandywine Global Investment Management held 789 positions worth $12.4B, down 3.3% from $12.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Brandywine Global Investment Management withdrew a net $488M in Q1 2023, closing 85 positions and reducing 357 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $69.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Brandywine Global Investment Management opened a new position in CSX Corp worth $53.2M.

  • Brandywine Global Investment Management's largest Q1 2023 buy was CSX Corp: 1,777,621 shares worth $53.2M.
  • Brandywine Global Investment Management added most to Amgen in Q1 2023, an estimated $52.7M increase.
  • Brandywine Global Investment Management's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $83.1M.
  • Brandywine Global Investment Management fully exited Regeneron Pharmaceuticals in Q1 2023, selling an estimated $69.1M.
  • Brandywine Global Investment Management's ten largest holdings make up 16% of its $12.4B portfolio in Q1 2023.
  • Brandywine Global Investment Management opened 69 new positions and closed 85 in Q1 2023.
  • Brandywine Global Investment Management's portfolio value fell 3.3% quarter-over-quarter to $12.4B.

Based on Brandywine Global Investment Management's 13F filing for Q1 2023, filed 12 May 2023.